Emiko Bryant
Chief of Staff, PEPGEN
Replay available
PepGen Inc. (NASDAQ: PEPG) Q4 2023 earnings conference call, held 2025-03-06. Replay captured from the company's public earnings webcast.

Chief of Staff, PEPGEN
President & Chief Executive Officer
Senior Vice President, Head of Clinical Development
Chief Financial Officer
Analyst, Bank of America
Analyst, H.C. Wainwright & Company
Watch the replay and follow the connected company analysis, news, and investor updates for Pepgen Inc..
WEBVTT 00:00:01.702 -- 00:00:07.070 Good afternoon and welcome to PEPGEN's fourth quarter and full year 2023 earnings 00:00:07.070 -- 00:00:11.977 call to discuss its financial results and recent corporate developments. 00:00:11.977 -- 00:00:14.881 At this time, all participants are in a listen-only mode. 00:00:14.881 -- 00:00:19.768 Following the manager's prepared remarks, we will hold a question and answer session. 00:00:19.768 -- 00:00:22.930 To ask a question during the session, 00:00:22.973 -- 00:00:28.500 ask a question at that time, please press star followed by 11 on your 00:00:28.500 -- 00:00:33.639 touchtone phone. As a reminder, this call is being recorded today, Thursday, March 00:00:33.639 -- 00:00:38.684 6, 2024. I would now like to turn the conference call over to 00:00:38.684 -- 00:00:41.927 Emiko Bryant, Chief of Staff of PEPGEN. 00:00:41.927 -- 00:00:45.089 Emiko, please go ahead. 00:00:47.253 -- 00:00:51.257 Thank you, operator. Good afternoon, everyone, and thank you for joining today's call. 00:00:51.257 -- 00:00:55.181 Earlier today, we released our financial results for the fourth quarter and full year 00:00:55.181 -- 00:00:59.633 2023 and provided an update on recent corporate developments. 00:00:59.633 -- 00:01:04.658 The press release and our 10-K files with the SEC this afternoon outlining our financial 00:01:04.658 -- 00:01:09.161 results are both available on our website at pepgen.com. 00:01:09.664 -- 00:01:14.989 Joining me on the call today are James McArthur, PhD, President and Chief Executive 00:01:14.989 -- 00:01:20.195 Officer, Dr. Michelle Melian, Senior Vice President, Head of Clinical Development, 00:01:20.195 -- 00:01:22.517 and Noel Donnelly, Chief Financial Officer. 00:01:22.517 -- 00:01:28.068 As a reminder, we will be makin...